Why is Shelter Pharma falling/rising?
2025-12-03 01:04:39Persistent Downward Trend Against Market Benchmarks Shelter Pharma’s share price has been on a downward trajectory over multiple time frames, markedly underperforming the Sensex. Over the past week, the stock has declined by 7.99%, while the Sensex gained 0.65%. The one-month performance shows a sharper fall of 10.26% for Shelter Pharma compared to a 1.43% rise in the Sensex. Year-to-date, the stock has plummeted by 32.87%, starkly contrasting with the Sensex’s 8.96% gain. Even over the last year, Shelter Pharma’s shares have fallen 28.46%, whereas the benchmark index rose by 6.09%. This sustained underperformance highlights significant challenges facing the company or its sector, which have not been offset by broader market gains. Price Action and Volatility o...
Read MoreWhy is Shelter Pharma falling/rising?
2025-11-13 23:57:35As of 13-Nov, Shelter Pharma Ltd is experiencing a decline in its stock price, currently at 41.25, which represents a decrease of 0.81 or 1.93%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 7.72% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. While there has been a slight increase in investor participation with a delivery volume rise of 6.06% against the 5-day average, the overall performance remains negative, with the stock down 0.84% over the past month and 26.06% year-to-date. In the broader market context, Shelter Pharma's recent performance contrasts with the benchmark Sensex, which has gained 1.40% over the past week and 2.61% over the past month. This underperformance highlights the stock's struggles relative to the mar...
Read MoreHow has been the historical performance of Shelter Pharma?
2025-11-12 23:35:19Answer: The historical performance of Shelter Pharma shows a consistent growth trajectory in net sales and profitability over the years. Breakdown: Shelter Pharma's net sales have steadily increased from INR 30.06 crore in March 2022 to INR 50.66 crore in March 2025. This growth is accompanied by a rise in total operating income, which reached INR 50.66 crore in March 2025, up from INR 30.06 crore in March 2022. The company's total expenditure also grew, amounting to INR 40.59 crore in March 2025, compared to INR 27.38 crore in March 2022. Operating profit (PBDIT) has shown significant improvement, rising from INR 2.68 crore in March 2022 to INR 10.08 crore in March 2025, reflecting an operating profit margin of 19.88% in the latest fiscal year. Profit before tax increased from INR 2.51 crore in March 2022 to INR 9.68 crore in March 2025, with profit after tax also rising from INR 1.84 crore to INR 7.24 cr...
Read MoreWhy is Shelter Pharma falling/rising?
2025-11-11 00:14:31As of 10-Nov, Shelter Pharma Ltd's stock price is rising, currently at Rs 44.10, reflecting an increase of Rs 2.24 or 5.35%. The stock has shown a positive performance today, outperforming its sector by 4.3%, and has been on a consecutive gain for the last two days, accumulating a total return of 7.98% during this period. It opened with a gain of 2.7% and reached an intraday high of Rs 46.51, which is an increase of 11.11%. Despite this upward movement, the stock has a year-to-date decline of 20.95% and a one-year decline of 18.38%, indicating a challenging longer-term performance. There is no information available regarding positive or negative factors that could further explain the stock's recent movement. Broader Market Context: In the short term, Shelter Pharma's stock has outperformed the benchmark Sensex, which has seen a decline of 0.53% over the past week while Shelter Pharma has increased by 6.27%...
Read MoreAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
02-Feb-2026 | Source : BSEShelter Pharma Limited Launch a new Products Fitkick Pro with Three Different Flavors
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
27-Jan-2026 | Source : BSEIntimation with Regards to Shelter Pharma Secured Order from Taha Drugs & Chemicals Co. Ltd Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclousure Requirements) Regulation 2015
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
23-Jan-2026 | Source : BSEIntimation with Regards to Shelter Pharma Secured Order from Taha Drugs & Chemicals Co. Ltd Pursuant to Regulation 30 of SEBI ( Listing Obligation and Disclousure Requirement) Regulation 2015
Corporate Actions
No Upcoming Board Meetings
Shelter Pharma Ltd has declared 3% dividend, ex-date: 23 Sep 25
No Splits history available
No Bonus history available
No Rights history available